powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1467893826
Ameya Hodarkar
MD
Endocrinology
Burlington,
MA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
79.2
Quality
61.7
Cost
81.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.17%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$312
Payment records
12
By payment type
Food and Beverage
$312
Top paying entities
Food and Beverage
$312
PRESCRIBING · PART D · 2024
Total Rx claims
11,229
Beneficiaries
—
Total drug cost
$5.5M
Distinct drugs
55
Brand share
55.9%
Top prescribed drugs
Levothyroxine Sodium
1,197 claims
Metformin Hcl
1,116 claims
Empagliflozin
1,069 claims
Semaglutide
554 claims
Tirzepatide
507 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,157
Unique beneficiaries
—
Total services
5,203
Distinct HCPCS
24
Medicare payment
$134K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 341 Endocrinology providers in MA — top quintile (cohort median 496).
